Siena Capital’s ResMed RMD Stock Holding History

Siena Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$11K	Hold	50	–	–	0.01%	120
2022 Q2	$10K	Hold	50	–	–	0.01%	167
2022 Q1	$12K	Buy	+50	New	+$12.1K	0.01%	199

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Siena Capital's RMD Position: Q3 2022 in Review

Siena Capital held its ResMed (RMD) position steady in Q3 2022 at 50 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #120.

Siena Capital first reported a position in RMD in Q1 2022 and has held it in 3 quarters since. The position peaked at $12K in Q1 2022. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

Siena Capital held 50 shares of ResMed worth $11K as of Q3 2022.
Siena Capital left its ResMed share count unchanged in Q3 2022.
ResMed made up 0.01% of Siena Capital's portfolio in Q3 2022, its #120 holding.
Siena Capital first reported a position in ResMed in Q1 2022 and has held it in 3 quarters since.
Siena Capital's ResMed position peaked at $12K in Q1 2022.
667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.